Shannon James Samuel
- SEC CIK
- 0001485417
In the past year, 1 open-market purchase filing worth $44.0K and no sales.
Current role at each company
- XLO Xilio Therapeutics, Inc.Directoras of Jun 12, 2026
- MNKD Mannkind CorpDirectoras of May 22, 2026
- HZNP Horizon Therapeutics Public Ltd CoDirectoras of Oct 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $44.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$44.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Shannon James Samuel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XLO Xilio Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2025 (view filing) | Jun 16-17 | 2 days | Shannon James SamuelDirector | PPurchase | +70.0K | $0.69 | +$48.3K | New position70.0K after | 2 lots |
| Mar 30, 2026 (view filing) | Mar 26 | 4 days | Shannon James SamuelDirector | PPurchase | +5.00K | $8.79 | +$44.0K | +100.0%10.0K after |